Seminar: Accelerating Formulation Development with AI

San Antonio, United States | 11 November 2025
Overview

Join Quotient Sciences and Intrepid Labs for an exclusive breakfast seminar exploring how artificial intelligence (AI) is transforming formulation development. Learn how AI platforms are helping reduce development timelines, optimising formulation strategies and improving predictability of clinical performance. 

This session will highlight real-world applications, including how Intrepid’s proprietary AI algorithm, AndromedaTM, can be combined with Translational Pharmaceutics® - a disruptive approach to drug development - to accelerate entry into the clinic, reduce API consumption, and enhance formulation decision-making in clinical development.  

Key Learnings for Attendees

  • Understand the role of AI in formulation development
  • Learn how formulation design has been streamlined for modified release products.  
  • Discover the potential benefits of combining AI with Translational Pharmaceutics®
  • See how this integration accelerates clinical timelines and improves formulation lock-in.
  • Gain insights into future applications and research     

Engage in open discussion and participate in a Q&A session to explore what the future of drug development may look like. 

Time/DateVenue

7:30 AM - 9:00 AM

Tuesday, November 11th 2025

Grand Hyatt San Antonio River Walk 

600 E Market St, San Antonio

TX 78205, United States 

Register
Location
Grand Hyatt San Antonio River Walk
600 E Market St, TX 78205
San Antonio, United States

Meet our experts:

We look forward to meeting you at the seminar.

Dr. Andrew Lewis

Chief Scientific Officer

Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams...

About Andrew
Dr Christine Allen

Co-Founder & CEO Intrepid Labs

Dr. Christine Allen is CEO and co-founder of Intrepid Labs Inc., a company leveraging AI, automation, and deep pharmaceutical expe...

More insight from our experts:

Read More
Drug Product, Commercial Manufacturing, Clinical Trial Manufacturing, Translational Pharmaceutics, Regulatory, Orphan Rare, FDA Navigating Expedited Drug Development Pathways Globally: Q&A with Quotient Sciences Experts
Learn more
Drug Development Consulting, Translational Pharmaceutics, Formulation Development, Drug Product, Careers The Strategic Role of Drug Development Consultants at Quotient Sciences
Learn more
Translational Pharmaceutics, Formulation Development, Peptides, Dr. Andrew Lewis Using a formulation design space with Translational Pharmaceutics® for success in oral peptide development
Learn more